[Federal Register Volume 82, Number 167 (Wednesday, August 30, 2017)]
[Notices]
[Pages 41276-41277]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18426]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment

AGENCY: Health Resources and Service Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, notice 
is hereby given that a meeting is scheduled for the Centers for Disease 
Control and Prevention (CDC)/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment. This meeting will be open 
to the public. Information about the CDC/HRSA Advisory Committee on 
HIV, Viral Hepatitis and STD Prevention and Treatment and the agenda 
for this meeting can be obtained by contacting CDR Holly Berilla at 
(301) 443-9965 or [email protected].

DATES: October 25, 2017, 9:00 a.m. to 5:30 p.m. (Eastern) and October 
26, 2017, 9:00 a.m. to 4:15 p.m. (Eastern).

ADDRESSES: This meeting will be held in person and offer virtual access 
through teleconference and Adobe Connect. The address for the meeting 
is 5600 Fishers Lane, Pavilion, Rockville, Maryland 20857. The 
conference call-in number is (888) 469-0566 and passcode is 6012320. 
The webinar link is https://hrsa.connectsolutions.com/october_chac_meeting/.

FOR FURTHER INFORMATION CONTACT: Those requesting information regarding 
the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment should contact CDR Holly Berilla, Senior 
Public Health Analyst, Division of Policy and Data (DPD), HIV/AIDS 
Bureau (HAB), HRSA, in one of three ways: (1) Mail a request to CDR 
Holly Berilla, Senior Public Health Analyst, HRSA/HAB/DPD, 5600 Fishers 
Lane, 9N164C, Rockville, Maryland 20857; (2) call (301) 443-9965; or 
(3) send an email to [email protected].

SUPPLEMENTARY INFORMATION: The CDC/HRSA Advisory Committee on HIV, 
Viral Hepatitis and STD Prevention and Treatment was established under 
Section 222 of the Public Health Service Act, [42 U.S.C. Section 217a], 
as amended.
    The purpose of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment is to advise the Secretary 
of HHS, the Director of CDC, and the Administrator of HRSA regarding 
objectives, strategies, policies, and priorities for HIV, viral 
hepatitis, and other STDs; prevention and treatment efforts including 
surveillance of HIV infection, AIDS, viral hepatitis and other STDs, 
and related behaviors; epidemiologic, behavioral, health services, and 
laboratory research on HIV/AIDS, viral hepatitis, and other STDs; 
identification of policy issues related to HIV/viral hepatitis/STD 
professional education, patient healthcare delivery, and prevention 
services; HHS policies about prevention of HIV/AIDS, viral hepatitis 
and other STDs; treatment, healthcare delivery, and research and 
training; strategic issues influencing the ability of CDC and HRSA to 
fulfill their missions of providing prevention and treatment services; 
programmatic efforts to prevent and treat HIV, viral hepatitis, and 
other STDs; and support to CDC and HRSA in their development of 
responses to emerging health needs related to HIV, viral hepatitis, and 
other STDs.
    During the October 25 to 26, 2017, meeting, the CDC/HRSA Advisory 
Committee on HIV, Viral Hepatitis and STD Prevention and Treatment will 
discuss strategies to link, retain, and re-engage people living with 
HIV into the Ryan White HIV/AIDS Program system of care; HAB's 
benchmarking and risk adjustment initiatives; HRSA and CDC initiatives 
regarding congenital syphilis; and committee workgroup reports. Agenda 
items are subject to change as priorities dictate.
    Members of the public will have the opportunity to provide 
comments. Oral comments will be honored in the order they are requested 
and may be limited as time allows. Requests to make oral comments or 
provide written comments to the CDC/HRSA Advisory Committee on HIV, 
Viral Hepatitis and STD Prevention and Treatment should be sent to CDR 
Holly Berilla, using the contact information listed above, by October 
11, 2017.
    The building at 5600 Fishers Lane, Rockville, MD 20857, requires a 
security screening on entry. To facilitate your access to the building 
please contact CDR Holly Berilla (contact information provided above). 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify CDR Holly Berilla (contact information provided above) at least 
10 days prior to the meeting.

[[Page 41277]]

    Status: This advisory committee meeting will be open to the public.

Amy McNulty,
Acting Director, Division of the Executive Secretariat.
[FR Doc. 2017-18426 Filed 8-29-17; 8:45 am]
 BILLING CODE 4165-15-P